Clinical trial

Femoral Nerve Block Versus. Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament Reconstruction: Evaluation of Post-Operative Pain and Strength

Name

10083

Description

All patients over the age of 16 undergoing primary or revision anterior cruciate ligament reconstruction with the use of bone-patellar-bone autograft are eligible for the study. Patients will be randomized pre-operatively to receive either an adductor canal nerve block (single injection) or a femoral nerve block (single injection). Post-operatively, the primary outcome measures of pain level using visual analog scale as well as narcotic and non-narcotic analgesic requirements will be measured.

Trial arms

Trial start

2016-05-01

Estimated PCD

2017-07-31

Trial end

2017-12-31

Status

Completed

Treatment

Marcaine 0.25 % Injectable Solution

For the adductor canal block, 20 mL of 0.25% marcaine will be injected with the use of ultrasound guidance into the adductor canal by the attending anesthesiologist on the case in the pre-op holding area.

Arms:

Adductor Canal Nerve Block

Marcaine 0.25 % Injectable Solution

For the femoral nerve block, 30 mL of 0.25% marcaine will be injected with the use of ultrasound guidance around the femoral nerve sheath by the attending anesthesiologist on the case in the pre-op holding area.

Arms:

Femoral Nerve block

Size

Primary endpoint

Visual Analog Scale

Post-op Day 0-5

Narcotic Requirement

Post-op Day 0-5

Eligibility criteria

Inclusion Criteria: * Primary ACL Reconstruction with use of Bone-Patellar-Bone Autograft * Age 16 or older Exclusion Criteria: * Patients under 16 * The use of Allograft, * The use of hamstring autograft * The use quadriceps autograft * Patients allergic to active ingredients in the injection.

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}}, 'enrollmentInfo': {'count': 78, 'type': 'ACTUAL'}}

Updated at

2024-02-20

1 organization

1 product

1 indication

Organization

Henry Ford Health System

Product

Marcaine

Indication

Pain